Literature DB >> 27461645

A clinicoepidemiological study of young age bladder tumors: An eastern Indian scenario.

Jitendra Pratap Singh1, Vinod Priyadarshi1, Dilip Kumar Pal1.   

Abstract

INTRODUCTION: Though, bladder cancer is one of the most common urological malignancies, studies addressing the young age group bladder tumors are rare. Present study was done to determine the clinicoepidemiological aspects of bladder tumor diagnosed in young age patients and to compare these aspects with elderly patients. PATIENTS AND METHODS: Patients with urinary bladder tumor were selectively divided into two groups; young (<40 years) and elderly (>60 years). Groups were compared on various parameters and statistically analyzed using Fisher's exact two-tailed test.
RESULTS: Smoking, tea and coffee intake and exposure of dye were found significantly associated with development of bladder tumor. Most of the tumors in young age were small, solitary, and papillomatous. Transitional cell carcinoma (TCC) was the most common histological subtype, though most were of low grade and were non-muscle invasive in comparison to the tumors in elderly group.
CONCLUSION: The incidence of bladder cancer is common in younger age group. Active and passive cigarette smoking, tea, coffee intake, and exposure to organic dyes are major risk factor for younger age group bladder tumor in this part of world. TCC is most common histological subtype and most of them are in low grade without muscle invasion.

Entities:  

Mesh:

Year:  2016        PMID: 27461645     DOI: 10.4103/0973-1482.154028

Source DB:  PubMed          Journal:  J Cancer Res Ther        ISSN: 1998-4138            Impact factor:   1.805


  1 in total

1.  N6-methyladenosine-related single-nucleotide polymorphism analyses identify oncogene RNFT2 in bladder cancer.

Authors:  Jiancheng Lv; Qiang Song; Kexin Bai; Jie Han; Hao Yu; Kai Li; Juntao Zhuang; Xiao Yang; Haiwei Yang; Qiang Lu
Journal:  Cancer Cell Int       Date:  2022-10-05       Impact factor: 6.429

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.